Edited by Ruma BanerjeeAldehyde dehydrogenase typically performs oxidation of aldehydes to their corresponding carboxylic acid while reducing NAD(P)؉ to NAD(P)H via covalent catalysis mediated by an active-site cysteine residue. These data establish a hidden intrinsic isomerization activity of the dehydrogenase and allow us to propose a pitcher-catcher type of catalytic mechanism for the isomerization.The kynurenine pathway is the catabolic route for tryptophan degradation in mammals and certain bacteria. In mammals, the pathway has been found to produce neuroactive compounds that correlate with depression and neurodegenerative disease states such as Alzheimer's, Parkinson's, and Huntington's diseases (1-3). Moreover, the kynurenine pathway is a de novo biosynthetic route to produce the coenzyme NAD ϩ / NADH, which is involved in many fundamental biological processes as an energy carrier and redox mediator. In the kynurenine pathway, tryptophan metabolites are partitioned by both enzymatic and non-enzymatic reactions (4). Three consecutive enzymes of the pathway, 3-hydroxyanthranilate dioxygenase (HAO), 3 2-amino-3-carboxymuconate-6-semi-aldehyde decarboxylase (ACMSD), and 2-amino-muconate-6-semialdehyde dehydrogenase (AMSDH), compete with the non-enzymatic auto-cyclization of their substrates and products for further metabolism (Fig. 1). The trio of enzymes is also present in the 2-nitrobenzoic acid biodegradation pathway.Investigations at the molecular level of the kynurenine pathway were extended to AMSDH in our recent work (5). AMSDH is a 216-kDa homotetrameric protein (500 amino acid residues in each subunit) that belongs to the aldehyde dehydrogenase superfamily. It competes with a spontaneous, non-enzymatic cyclization of 2-aminomuconate semialdehyde (2-AMS) to prevent overproduction of picolinic acid. The off-pathway product, picolinic acid, is a metal chelator in human milk that is barely detectable in blood serum and below the detection limit in other tissues (6). AMSDH oxidizes 2-AMS to 2-aminomuconate and directs the metabolic flux to enzyme-controlled reactions. We have shown the anticipated enzymatic activity of AMSDH using isolated protein and determined its first crystal structure (5). Furthermore, the binary and ternary complexes as well as two catalytic intermediates, thiohemiacetal and thioacyl, were characterized by soaking single crystals of the binary enzyme-NAD ϩ complex under varied time periods with substrates, widening our knowledge of the catalytic mechanism of this semialdehyde dehydrogenase.